UPF1 and renal cell carcinoma: Mao found that lncRNA-SLERCC (SLERCC) was lowly expressed in renal cell carcinoma, and further exploration revealed that SLERCC interacted directly with UPF1 and inhibited renal cell carcinoma development through the WNT/β-catenin signaling pathway.